Image

Exercise Prehabilitation in Congenital Heart Disease

Exercise Prehabilitation in Congenital Heart Disease

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Around 8-12 in every 1000 babies are born with an abnormal heart, known as a congenital heart defect (CHD).

Thanks to major advances in medical and surgical care, most babies born with CHD now live into adulthood.

As people with CHD get older, many need repeated heart operations. It is known from other areas of medicine that "prehabilitation" - a short, structured exercise programme completed before surgery - can improve fitness and help patients cope better with major operations. However, this approach has never been tested in adults with CHD. The investigators are running a randomised controlled trial to find out whether a prehabilitation programme can improve physical fitness before heart surgery in adults with CHD.

Participants will be randomly assigned to usual care or a prehabilitation group. Those in the prehabilitation group will follow a tailored, supervised exercise plan for several weeks before surgery.

All patients undergoing cardiac surgery routinely complete a cardiopulmonary exercise test (CPET) as part of their standard pre-operative assessment. CPET is a well-established test that shows how the heart and lungs respond to increasing levels of exercise. During the test, participants exercise on a bike while their breathing, heart rate, and overall physiological response are continuously monitored.

The results of each participant's routine CPET will be used to guide the individualised exercise programme in the intervention group.

Exercise levels prescribed in the study will not exceed the intensity already safely achieved during the routine CPET, ensuring that activity remains within clinically assessed limits.

Participants in the trial will complete an additional second CPET following the trial period.

The key question is whether a tailored exercise programme can improve fitness in adults with CHD before heart surgery, and whether this approach is feasible, acceptable and practical to deliver, including successful recruitment and measurable physiological improvements.

Eligibility

Inclusion Criteria:

  • Adults with congenital heart disease requiring cardiac surgery via sternotomy or thoracotomy.
  • Capacity to provide informed consent.
  • Ability and willingness to engage in exercise-based interventions.
  • Peak VO2 \<30ml/kg/min at preoperative exercise assessment.
  • Participant reached peak VO2 in preoperative exercise assessment (RER \>1.0).
  • Ability to communicate in English.

Exclusion Criteria:

  • Surgery is scheduled for a date that precludes participation in the programme - surgical date is \<9 weeks away.
  • Pregnancy of \<6 months postpartum.
  • History of pneumothorax within the last 3 months.
  • Resting oxygen saturations \<94%.
  • Uncorrected right-to-left shunt with exercise.
  • Fontan physiology.
  • Pulmonary hypertension.
  • Critical valvular obstruction.
  • Sustained ventricular arrhythmia.
  • Severe aortic dilatation (\>45mm in Marfan syndrome or hereditary aortopathy, \>50mm in bicuspid or tricuspid aortic valves).

The oldest person operated upon by the ACHD service was 78 years old. Upper age is not an exclusion criteria.

Study details
    Congenital Heart Disease
    Cardiac Surgery

NCT07700459

Liverpool Heart and Chest Hospital NHS Foundation Trust

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.